Table 2.
Clinical characteristics of PAD patients.
| Variables | PAD Treatment (n = 10) | PAD No-Treatment (n = 10) |
|---|---|---|
| Mean age, y * | 69.6 ± 8.2 | 75.6 ± 7.6 |
| Males/females | 7/3 | 6/4 |
| Hypertension, % (n) | 90% (9) | 90% (9) |
| Diabetes mellitus, % (n) | 30% (3) | 40% (4) |
| Dyslipidemia, % (n) | 80% (8) | 50% (5) |
| Former smokers, % (n) | 40% (4) | 20% (2) |
| CHD | 30% (3) | 50% (5) |
| Previous stroke | 10% (1) | 0% (0) |
| BMI * | 26.1 ± 3 | 25.2 ± 3 |
| Pharmacological treatments, % (n) | ||
| ACE-inhibitors | 50% (5) | 100% (10) |
| Statin | 90% (9) | 100% (10) |
| Antiplatelets | 100% (10) | 100% (10) |
| Oral anticoagulants | 0% (0) | 0% (0) |
ACE, angiotensin-converting enzyme; BMI, body mass index; CHD, coronary heart disease; PAD, peripheral artery disease. * Data are expressed as mean ± SD.